Heparin-coated extracorporeal circulation systems in heart surgery

Recent Patents on Cardiovascular Drug Discovery

Volumn 4, Issue 3, 2009, Pages 177-179

  Tagarakis, Georgios I ^a   Tsilimingas, Nikolaos B ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

Bioactive surface; Extracorporeal circulation; Heart surgery; Heart lung machine; Heparin; Postoperative hemorrhage; Systemic inflammatory response

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

BLEEDING; CLINICAL TRIAL; DRUG COATING; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG STRUCTURE; EXTRACORPOREAL CIRCULATION; EXTRACORPOREAL OXYGENATION; HEART SURGERY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THORACIC AORTA ANEURYSM;

EID: 76149120865     PISSN: 15748901     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489009789152212     Document Type: Review

References (21)

1. Greek National Drug Organization-Pharmaceutical Guide Athens; Greece 2003: 135-136.
2. Linhardt RJ, Ampofo SA, Fareed J, et al. Isolation and characterization of human heparin. Biochemistry 1992; 31(49): 12441-12445.
3. Mulloy B, Forster MJ, Jones C, Davies DB. NMR and molecular-modelling studies of the solution conformation of heparin. Biochem J 1993; 293: 849-858.
4. Chuang YJ, Swanson R. Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin. J Biol Chem 2001; 276(18): 14961-14971.
5. Handoll HHG, Farrar MJ, McBirnie J, Tytherleigh-Strong G, Milne AA, Gillespie WJ. Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures. Cochrane Database Syst Rev 2002; 4: CD000305.
6. Zamora, P.O.: US20087468210 (2008).
7. Ding, N., Raeder-Devens, J.E., Trinh, T.T.: US5879697 (1999).
8. Mirow N, Zittermann A, Koertke H, et al. Heparin-coated extracorporeal circulation in combination with low-dose systemic heparinization reduces early postoperative blood loss in cardiac surgery. J Cardiovasc Surg (Torino) 2008; 49(2): 277-284.
9. Mangoush O, Purkayastha S, Haj-Yakia S, et al. Heparin-bonded circuits versus non heparin-bonded circuits: An evaluation of their effect on clinical outcomes. Eur J Cardiothorac Surg 2007; 31(6): 1058-1069.
10. Kreisler KR, Vance RA, Cruzzavala J, Makken JD. Heparin-bonded cardiopulmonary bypass circuits reduced the rate of red blood cell transfusion during elective coronary artery bypass surgery. J Cardiothorac Vasc Anesth 2005; 19(5): 608-611.
11. Heyer EJ, Lee KS, Manspeizer HE, et al. Heparin-bonded cardiopulmonary bypass circuits reduce cognitive dysfunction. J Cardiothorac Vasc Anesth 2002; 16(1): 37-42.
12. Miyaji K, Hannan RL, Ojito J, Jacobs JP, White JA, Burke RP. Heparin-coated cardiopulmonary bypass circuit: Clinical effects in pediatric cardiac surgery. J Card Surg 2000; 15(3): 194-198.
13. Collart F, Cous T, Pomane C, et al. Clinical evaluation of heparincoated circuits for routine coronary artery bypass grafting surgery: A prospective randomized study. Artif Organs 2000; 24(8): 611-613.
14. Tayama E, Hayashida N, Akasu K, et al. Biocompatibility of heparin-coated extracorporeal bypass circuits: New heparin bonded bioline system. Artif Organs 2000; 24(8): 618-623.
15. Levy M, Hartman AR. Heparin-coated circuits in cardiopulmonary bypass: Improved biocompatibility or not. Int J Cardiol 1996; 53: 81-87.
16. Morishita K, Kawaharada N, Fukada J, et al. Descending thoracic aortic aneurysm repair with the aid of partial cardiopulmonary bypass: Heparin-coated circuits versus non heparin-coated circuits. Artif Organs 2005; 29(4): 300-305.
17. Urlesberger B, Zobel G, Roedl S, et al. Activation of the clotting system: Heparin-coated versus non coated systems for extracorporeal circulation. Int J Artif Organs 1997; 20(12): 708-712.
18. Castiglioni A, Verzini A, Pappalando F, et al. Minimally invasive closed circuit versus standard extracorporeal circulation for aortic valve replacement. Ann Thorac Surg 2007; 83(2): 586-591.
19. Sakwa MP, Emery RW, Shannon FL, et al. Coronary artery bypass grafting with a minimized cardiopulmonary bypass circuit: A prospective, randomized trial. J Thorac Cardiovasc Surg 2009; 137(2): 481-485.
20. Schoettler J, Lutter G, Boening A, et al. Is there really a clinical benefit of using ectracorporeal circulation for coronary artery bypass grafting? Thorac Cardiovasc Surg 2008; 56(2): 65-70.
21. Koster A, Loebe M, Sodian R, et al. Heparin antibodies and thromboembolism in heparin coated and non-coated ventricular assist devices. J Thorac Cardiovasc Surg 2001; 121(2): 331-335.